Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_assertion type Assertion NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_head.
- NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_assertion wasGeneratedBy ECO_0000203 NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_provenance.
- NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_assertion wasDerivedFrom befree-20150227 NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_provenance.
- NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_assertion SIO_000772 21220499 NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_provenance.
- NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_assertion evidence source_evidence_literature NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_provenance.
- NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_assertion description "[In conclusion, we found that sorafenib exerts a potent inhibitory activity against the EMT by inhibiting MAPK signaling and SNAI1 expression in HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704536.RAGZOYRXBEamwEWOgfXmwR6ZKQjG8d7HLJA1GqjtP3WRk130_provenance.